Claims
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In the study’s eight-center external CT test cohorts, EAGLE achieved 98.5% specificity, 90.0% cancer sensitivity and 52.5% precancerous-lesion sensitivity. | QUANTITATIVE | Supported | 0.9781 | 1 of 4 | 143 |